After a remarkable three-year run, Rocket Lab USA (NASDAQ: RKLB) finds itself in a zone where valuation signals are sending mixed and cautious messages to investors. A Discounted Cash Flow model estimates Rocket Lab’s intrinsic value at roughly $81.92 per share, placing the stock at approximately 1.1% overvalued relative to that figure at current trading levels. The near-alignment between the DCF estimate and the market price suggests the stock is broadly fairly valued on a cash flow basis, though that conclusion depends heavily on future recovery in free cash flow generation. Despite the DCF alignment, Rocket Lab scores 0 out of 6 on Simply Wall St’s broader valuation checks, indicating the company does not screen as a bargain across most traditional financial metrics. Rocket Lab delivered 85.3% returns over the last year, a performance that comfortably outpaced much of the broader Aerospace and Defense industry during that period.